dactinomycin has been researched along with Precursor Cell Lymphoblastic Leukemia-Lymphoma in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 8 (57.14) | 18.2507 |
| 2000's | 4 (28.57) | 29.6817 |
| 2010's | 2 (14.29) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baert, JL; Brenner, C; de Launoit, Y; Mauen, S; Monté, D; Moser, M; Putmans, P; T'sas, F; Van Lint, C | 1 |
| Felix, CA; Hosler, MR; Lange, BJ; Masterson, M; Wilson, AE; Winick, NJ | 1 |
| Beck, J; Ehninger, G; Frese, G; Gekeler, V; Handgretinger, R; Neumann, M; Niethammer, D; Noller, A; Probst, H; Wilisch, A | 1 |
| Amley, J; Chan, PK; Koller, CA; Qi, Y | 1 |
| du Manoir, S; Fojo, T; Green, ED; Knutsen, T; Macville, M; Mickley, LA; Ning, Y; Polymeropoulos, M; Ried, T; Robey, R; Schröck, E; Torres, R | 1 |
| Abe, T; Aizawa, Y; Fuse, I; Hashimoto, S; Itoh, H; Koike, T; Shibazaki, Y; Takahashi, H; Takahashi, M; Toba, K; Watanabe, K; Yano, T | 1 |
| Weiss, M | 1 |
| Blair, IA; Felix, CA; Lo Nigro, L; Lovett, BD; Megonigal, MD; Nowell, PC; Osheroff, N; Rappaport, EF; Williams, WR; Zheng, N | 1 |
| Holte, H; Lie, SO; Smeland, EB; Steen, HB; Stokke, T | 1 |
| Miyachi, H; Ohnuma, T; Sekiguchi, S; Takemura, Y | 1 |
| Gekeler, V; Probst, H; Weger, S | 1 |
| Imashioya, T; Imuta, N; Kawano, Y; Kirishima, M; Kodama, Y; Koriyama, T; Nakagawa, S; Nishi, J; Nishikawa, T; Okamoto, Y; Ooka, T; Tanabe, T; Tanimoto, A | 1 |
| Honda, T; Horiuchi, K; Kasuga, E; Matsumoto, T; Natori, T; Negishi, T; Saito, S; Sugano, M; Takehara, K | 1 |
| Horiike, S; Iwai, T; Kaneko, H; Kashima, K; Misawa, S; Nakazawa, N; Ohgawara, Y; Sasai, Y; Tamura, A; Taniwaki, M; Tsuda, S; Ueda, Y; Yokota, S | 1 |
1 review(s) available for dactinomycin and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Induction therapy of adult acute lymphocytic leukemia without the use of vincristine or prednisone.
Topics: Adolescent; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carmustine; Clinical Trials, Phase II as Topic; Clinical Trials, Phase III as Topic; Controlled Clinical Trials as Topic; Cyclophosphamide; Cytarabine; Dactinomycin; Doxorubicin; Etoposide; Female; Filgrastim; Granulocyte Colony-Stimulating Factor; Humans; Male; Mercaptopurine; Methotrexate; Middle Aged; Mitoxantrone; Multicenter Studies as Topic; Neutropenia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Prednisone; Prospective Studies; Randomized Controlled Trials as Topic; Recombinant Proteins; Remission Induction; Survival Analysis; Treatment Outcome; Vincristine | 2001 |
1 trial(s) available for dactinomycin and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
[Clinical evaluation of cefozopran for infections associated with hematological malignancies].
Topics: Acute Disease; Adult; Aged; Aged, 80 and over; Anemia, Aplastic; Bacterial Infections; Bronchitis; Cefozopran; Cephalosporins; Female; Granulocytes; Hodgkin Disease; Humans; Leukemia; Leukemia, Myeloid, Acute; Leukemia, T-Cell; Leukocyte Count; Lymphoma; Male; Middle Aged; Multiple Myeloma; Peritonitis; Pneumonia; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Sepsis; Severity of Illness Index | 1998 |
12 other study(ies) available for dactinomycin and Precursor Cell Lymphoblastic Leukemia-Lymphoma
| Article | Year |
|---|---|
Expression of the Ets transcription factor Erm is regulated through a conventional PKC signaling pathway in the Molt4 lymphoblastic cell line.
Topics: Cell Line, Tumor; Dactinomycin; DNA-Binding Proteins; Gene Expression Regulation; Humans; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Promoter Regions, Genetic; Protein Kinase C; RNA, Messenger; Sequence Deletion; Signal Transduction; T-Lymphocytes; Tetradecanoylphorbol Acetate; Transcription Factors; Transcription, Genetic; Up-Regulation | 2005 |
ALL-1 gene rearrangements in DNA topoisomerase II inhibitor-related leukemia in children.
Topics: Acute Disease; Adolescent; Bone Marrow Transplantation; Child; Child, Preschool; Chromosome Aberrations; Chromosome Deletion; Chromosomes, Human, Pair 11; Combined Modality Therapy; Dactinomycin; DNA-Binding Proteins; Etoposide; Female; Genes; Histone-Lysine N-Methyltransferase; Humans; Infant; Leukemia; Leukemia, Myeloid; Leukemia, Radiation-Induced; Male; Myelodysplastic Syndromes; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms; Neoplasms, Second Primary; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy; Teniposide; Topoisomerase II Inhibitors; Transcription Factors; Translocation, Genetic; Whole-Body Irradiation | 1995 |
Drug-induced changes in the expression of MDR-associated genes: investigations on cultured cell lines and chemotherapeutically treated leukemias.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Blast Crisis; Blotting, Northern; Carrier Proteins; Dactinomycin; DNA Topoisomerases, Type II; Drug Resistance; Gene Expression; Humans; Leukemia; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Membrane Glycoproteins; Molecular Sequence Data; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1994 |
Quantitation of the nucleophosmin/B23-translocation using imaging analysis.
Topics: Aclarubicin; Antibiotics, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Cell Nucleolus; Dactinomycin; Daunorubicin; Dose-Response Relationship, Drug; Fluorescent Antibody Technique; Humans; Image Processing, Computer-Assisted; Leukemia, Monocytic, Acute; Nuclear Proteins; Nucleophosmin; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1996 |
Cytogenetic and molecular characterization of random chromosomal rearrangements activating the drug resistance gene, MDR1/P-glycoprotein, in drug-selected cell lines and patients with drug refractory ALL.
Topics: Antibiotics, Antineoplastic; ATP Binding Cassette Transporter, Subfamily B, Member 1; Chromosome Aberrations; Chromosome Disorders; Chromosomes, Human, Pair 7; Dactinomycin; Doxorubicin; Drug Resistance, Microbial; Drug Resistance, Multiple; Gene Expression Regulation; Gene Rearrangement; Genes, MDR; Humans; In Situ Hybridization, Fluorescence; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured | 1998 |
Cell kinetic study of normal human bone marrow hematopoiesis and acute leukemia using 7AAD/PY.
Topics: Adult; Antigens, CD; Antigens, CD34; Bone Marrow Cells; Burkitt Lymphoma; Cell Cycle; Cells, Cultured; Dactinomycin; DNA; Hematopoiesis; Hematopoietic Stem Cells; Humans; Immunophenotyping; Kinetics; Leukemia; Leukemia-Lymphoma, Adult T-Cell; Leukemia, Myeloid, Acute; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA | 2000 |
Near-precise interchromosomal recombination and functional DNA topoisomerase II cleavage sites at MLL and AF-4 genomic breakpoints in treatment-related acute lymphoblastic leukemia with t(4;11) translocation.
Topics: Antigens, Neoplasm; Antineoplastic Combined Chemotherapy Protocols; Catechols; Child; Chromosome Breakage; Chromosomes, Human, Pair 11; Chromosomes, Human, Pair 4; Combined Modality Therapy; Cyclophosphamide; Dactinomycin; DNA Topoisomerases, Type II; DNA-Binding Proteins; DNA, Neoplasm; Etoposide; Female; Histone-Lysine N-Methyltransferase; Humans; Ifosfamide; Isoenzymes; Models, Genetic; Molecular Sequence Data; Myeloid-Lymphoid Leukemia Protein; Neoplasm Proteins; Neoplasms, Second Primary; Nuclear Proteins; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Proto-Oncogenes; Radiotherapy, Adjuvant; Recombination, Genetic; Rhabdomyosarcoma, Alveolar; Soft Tissue Neoplasms; Transcription Factors; Transcriptional Elongation Factors; Translocation, Genetic; Vincristine | 2001 |
Differential chromatin structure-dependent binding of 7-aminoactinomycin D in normal and malignant bone marrow hematopoietic cells.
Topics: Antigens, CD; Cell Cycle; Child; Chromatin; Dactinomycin; DNA; Flow Cytometry; Hematopoietic Stem Cells; Humans; Leukemia, Myeloid, Acute; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Survival Analysis; Transcription, Genetic | 1992 |
A human leukemia cell line made resistant to two folate analogues, trimetrexate and N10-propargyl-5,8-dideazafolic acid (CB3717).
Topics: Antineoplastic Agents; ATP Binding Cassette Transporter, Subfamily B, Member 1; Cell Division; Cell Line; Cisplatin; Cross Reactions; Dactinomycin; Dose-Response Relationship, Drug; Doxorubicin; Drug Resistance; Etoposide; Fluorouracil; Folic Acid; Humans; Leucovorin; Membrane Glycoproteins; Methotrexate; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Quinazolines; RNA, Messenger; Thymidylate Synthase; Trimetrexate; Vincristine | 1991 |
mdr1/P-glycoprotein gene segments analyzed from various human leukemic cell lines exhibiting different multidrug resistance profiles.
Topics: ATP Binding Cassette Transporter, Subfamily B, Member 1; Base Sequence; Cell Division; Cell Line; Cloning, Molecular; Dactinomycin; Doxorubicin; Drug Resistance; Humans; Membrane Glycoproteins; Molecular Sequence Data; Neoplasm Proteins; Polymerase Chain Reaction; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Tumor Cells, Cultured; Vincristine | 1990 |
Liver abscess due to Sterigmatomyces halophilus in a boy with acute lymphoblastic leukemia.
Topics: Amphotericin B; Antifungal Agents; Antineoplastic Agents; Basidiomycota; Biopsy; Bone Marrow Transplantation; Cefozopran; Cephalosporins; Chemotherapy-Induced Febrile Neutropenia; Child; Hematopoietic Stem Cell Transplantation; Humans; Liver; Liver Abscess; Male; Micafungin; Mycoses; Neoplasm Recurrence, Local; Precursor Cell Lymphoblastic Leukemia-Lymphoma; Treatment Outcome | 2019 |
Catheter-Related Bacteremia Due to Gordonia sputi in a Patient with Acute Lymphocytic Leukemia: a Case Report.
Topics: Actinomycetales Infections; Adolescent; Anti-Bacterial Agents; Bacteremia; Blood Culture; Catheter-Related Infections; Cefozopran; Cephalosporins; Gordonia Bacterium; Humans; Male; Precursor Cell Lymphoblastic Leukemia-Lymphoma; RNA, Ribosomal, 16S | 2016 |